Medicare Enrolled
Dr. Anna Longacre, MD
Gastroenterology · Marietta, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Longacre from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Longacre?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Longacre
Dr. Anna Longacre is a gastroenterology specialist in Marietta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Longacre performed 731 Medicare services across 676 unique beneficiaries.
Between the years covered by Open Payments, Dr. Longacre received a total of $15,252 from 47 pharmaceutical and/or device companies across 703 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Longacre is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 39% volume in GA
$15,252 industry payments
Medicare Practice Summary
Medicare Utilization ↗731
Medicare services
Top 39% in GA for gastroenterology
676
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~37 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
158 | $86 | $392 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
100 | $86 | $600 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
72 | $127 | $793 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
58 | $68 | $339 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
54 | $56 | $275 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
44 | $177 | $747 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
43 | $209 | $943 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
33 | $174 | $747 |
| Dilation of esophagus | 25 | $31 | $666 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
24 | $33 | $221 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
21 | $46 | $230 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
20 | $133 | $747 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
19 | $39 | $115 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
14 | $52 | $228 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
12 | $92 | $408 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
12 | $62 | $210 |
| Complete ultrasound of abdomen A diagnostic imaging test that uses sound waves to create detailed pictures of the organs and structures within the abdomen. |
11 | $63 | $347 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
11 | $102 | $400 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.9% high complexity
39.9% medium
57.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,252
Total received (2018-2024)
Avg $2,179/year across 7 years
Top 9% in GA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
703
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,169 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$84 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,752
2023
$3,032
2022
$2,786
2021
$1,828
2020
$1,220
2019
$1,607
2018
$1,027
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$636
GENZYME CORPORATION
$494
Janssen Biotech, Inc.
$419
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$287
PFIZER INC.
$175
Lilly USA, LLC
$174
Phathom Pharmaceuticals, Inc.
$171
Madrigal Pharmaceuticals
$170
Ardelyx, Inc.
$166
Intercept Pharmaceuticals, Inc.
$124
Mallinckrodt Hospital Products Inc.
$124
Gilead Sciences, Inc.
$113
E.R. Squibb & Sons, L.L.C.
$109
AIMMUNE THERAPEUTICS, INC.
$96
Janssen Scientific Affairs, LLC
$85
IRONWOOD PHARMACEUTICALS, INC
$80
Celgene Corporation
$75
Regeneron Healthcare Solutions, Inc.
$74
QOL Medical, LLC
$55
Celltrion USA Inc.
$49
Ipsen Biopharmaceuticals, Inc
$40
Organon Llc
$22
Takeda Pharmaceuticals U.S.A., Inc.
$15
Top 3 companies account for 41.3% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$2,492
AbbVie Inc.
$1,640
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,207
Janssen Biotech, Inc.
$1,120
GENZYME CORPORATION
$948
AbbVie, Inc.
$756
PFIZER INC.
$581
Janssen Scientific Affairs, LLC
$542
Regeneron Healthcare Solutions, Inc.
$495
Takeda Pharmaceuticals U.S.A., Inc.
$472
Celgene Corporation
$455
Gilead Sciences, Inc.
$416
Ardelyx, Inc.
$378
INTERCEPT PHARMACEUTICALS, INC.
$367
Ironwood Pharmaceuticals, Inc
$336
Intercept Pharmaceuticals, Inc.
$313
Merck Sharp & Dohme Corporation
$199
Lilly USA, LLC
$174
Phathom Pharmaceuticals, Inc.
$171
IRONWOOD PHARMACEUTICALS, INC
$170
Madrigal Pharmaceuticals
$170
Medtronic USA, Inc.
$148
Merck Sharp & Dohme LLC
$146
UCB, Inc.
$135
QOL Medical, LLC
$135
Medtronic, Inc.
$126
Mallinckrodt Hospital Products Inc.
$124
E.R. Squibb & Sons, L.L.C.
$109
Romark Laboratories, LC
$105
AIMMUNE THERAPEUTICS, INC.
$96
Dova Pharmaceuticals
$96
Celltrion USA Inc.
$84
Alfasigma USA, Inc.
$69
Nestle HealthCare Nutrition Inc.
$63
RedHill Biopharma Inc.
$63
Allergan Inc.
$48
Allergan, Inc.
$40
Ipsen Biopharmaceuticals, Inc
$40
Ferring Pharmaceuticals Inc.
$37
Mylan Institutional Inc.
$35
Alexion Pharmaceuticals, Inc.
$34
Boston Scientific Corporation
$27
Amgen Inc.
$22
Organon Llc
$22
Organon LLC
$17
NESTLE HEALTHCARE NUTRITION INC.
$15
Ethicon US, LLC
$11
Top 3 companies account for 35.0% of all-time payments
Associated products mentioned in payments ›
ALINIA · AMJEVITA · Aemcolo · Alinia · Alinia Tablets 500mg 30 count bottle · Amitiza · CIMZIA · CREON · Cimzia · Creon · DIFICID · DUPIXENT · Doptelet · ENTYVIO · Entyvio · Epclusa · GATTEX · GENERAL POLYPECTOMY · GI GENIUS · General - Polypectomy · HUMIRA · Hulio · Humira · IBSRELA · INFLECTRA · INTERSTIM · IQIRVO · LINZESS · Linzess · MAVYRET · MOTEGRITY · Mavyret · Movantik · OCALIVA · OMVOH · REBYOTA · RELISTOR · REMICADE · RENFLEXIS · RESMETIROM · REZDIFFRA · RINVOQ · SKYRIZI · STELARA · SUCRAID · Sucraid · TERLIVAZ · TREMFYA · TRULANCE · Talicia · UBRELVY · UCERIS · ULTOMIRIS · Ultomiris · VELSIPITY · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · YUFLYMA · ZENPEP · ZEPOSIA · ZYMFENTRA · Zelnorm
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for gastroenterology in GA.
Geographic Context
Gastroenterologists within 10 mi
190
Per 100K population
24.7
County median income
$98,712
Nearest hospital
WELLSTAR KENNESTONE REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Longacre is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 9% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Longacre experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Longacre performed 158 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Longacre receive payments from pharmaceutical companies?
Yes. Dr. Longacre received a total of $15,252 from 47 companies across 703 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Longacre's costs compare to other gastroenterologists in Marietta?
Dr. Longacre's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Longacre) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Marietta
Browse gastroenterologists in Marietta ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in GA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in GA
Which GA gastroenterologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology